ICU Medical’s Proposed $833m Leveraged Loan Repricing On Hold

Critical care company ICU Medical has put on hold a leveraged loan repricing that was scheduled to wrap up this week, according to a person with knowledge of the matter.

• A lender meeting for the $833 million term loan B took place on June 11, and commitments were due today
  • Price talk was SOFR+200-225, 0.50%, Par
  • Debt sale was set to mature in January 2029
• Proceeds from the offering were expected to reprice the company’s existing TLB issued in January 2022, which pays 250 basis point over the benchmark rate, according to data compiled by Bloomberg
• Representatives for Wells Fargo, ...